Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01159275Phase 2Completed
A Phase 2 trial of lopinavir, ritonavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by HIV-NAT. Started Jul 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01159275.